Pixium Vision Gets Clinical Trial Approval from Spanish Ministry of Health for 150 Electrode IrisII Bionic Vision System
Pixium Vision has received approval from the Spanish Ministry of Health for clinical trial with the IRISII bionic vision system for patients who have lost sight due to Retinitis Pigmentosa (RP).
According to a release, the IRISII system features include a mini bio-inspired camera and a 150-electrode epi-retinal implant with an explantable design.
Barcelona's Institute of Ocular Microsurgery IMO (Spain) joins the expanding network of centres of excellence in Europe involved in the clinical trial with IRISII. The Institute of Ocular Microsurgery is a ophthalmology center dedicated to the treatment of ocular diseases and the correction of vision. Patients in Spain will have the opportunity to participate in this European clinical trial.
Prof. Borja Corcostegui, Founder and Medical Director of the Institute of Ocular Microsurgery, IMO, a vitroretinal surgeon and the trial's principal investigator in Spain, said: "We are delighted to participate in the clinical trial with IRISII and become the first site in Spain. Patients blind from outer retinal degeneration in Spain can consider participation in assessing the innovative bionic vision system designed to regain a form of visual perception. Participation in clinical trials with innovative treatment options is essential for ophthalmology reference centres such as IMO. The partnership with Pixium Vision to develop solutions for retinal dystrophies, such as RP and, in the near future, Age-related Macular Degeneration (AMD), is consistent with our continuous commitment to offer cutting-edge treatment options to our patients."
Khalid Ishaque, CEO of Pixium Vision, said: "The approval of the clinical trial now in Spain reinforces our confidence in the IRISII, our first bionic vision system. Today, Pixium Vision is the only company developing an epi-retinal implant system for retinitis pigmentosa, and a sub-retinal wireless photovoltaic implant for AMD patients. We are proud to initiate this clinical collaboration in Spain with the internationally renowned Institute of Ocular Microsurgery, IMO."
In July 2016, Pixium Vision also received EU market approval for IRISII. Available under medical prescription, the bionic vision system offers a new treatment option to patients with retinitis pigmentosa. The Company can now also pursue reimbursement with the national healthcare systems. The ongoing prospective multi-centre clinical study protocol being conducted across several European ophthalmology reference centres, further enables building longer term evidence for the system performance.
((Comments on this story may be sent to firstname.lastname@example.org))
THE DAILY VIEW
Papyrus Joins Forces with Designer Lela Rose
Papyrus is looking to bring the “elegance and style” of fashion to its greeting cards via a new designer collaboration series.
According to a release, the collaboration marks the first time a fashion design house and greeting card brand have joined forces to develop a custom greeting card collection.
Papyrus said it is partnering with American fashion designer Lela Rose to introduce the series. Rose will feature her "sophisticated yet modern style" in the debut card and gift collection, slated to launch during New York Fashion Week. The collection will be available in New York City Papyrus stores and select retailers in September, with availability expanding to all Papyrus locations and retailers in October.
"The fashion designer collaboration series is a celebration of the commitment Papyrus has to the arts, including a focus on the fashion industry, quality craftsmanship and trend-forward design," said Christy Kaprosy, President of Papyrus-Recycled Greetings. "We are delighted to have Lela Rose's elegant line lead the first Papyrus fashion designer collaboration program, and we are excited to bring more fashion designers to our loyal customers in the future."
The company noted the collection, which draws inspiration from some of Rose's recent runway designs, consists of 16 cards and five gift accessories, including gift bags, gift tissue, roll wrap and a gift tag set. It also will be available online at papyrusonline.com
"I'm thrilled to be the first designer to collaborate with Papyrus on their exclusive new fashion series," said Lela Rose. "This is a unique way to showcase our designs, silhouettes and prints, and extend the brand into a new category."
- Big Gift: Bill Gates, founder and co-chair of the Bill & Melinda Gates Foundation, has committed $50 million to fight the epidemic.
- Early Donation: In August, Paul G. Allen Family Foundation donated $2.8 million toward the outbreak in West Africa.
- Latest Pledge: Facebook founder Mark Zuckerberg and his wife Priscilla Chan this month pledged $25 million to the CDC.
- Corporate Funds: World Bank Group in August pledged up to US $200 million in emergency funding to help Guinea, Liberia, and Sierra Leone contain the spread of infections.
- Crowdfunding: Scripps Research Institute's Erica Ollman Saphire seeks to raise $100K for equipment to speed her work, partially funding by U.S. government.